Clinical Trial Update: Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness [Phase 4]

View source ↗

Summary

Phase 4 trial update on novel pharmacotherapy approaches for nicotine dependence in smokers with serious mental illness, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Nicotine Dependence
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: University of California, San Diego | Conditions: Bipolar Disorder, Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2023-06-22